Incyte Corporation vs Reddit Inc — how do they compare? Incyte Corporation trades at $112.98 (market cap $22.85B), while Reddit Inc trades at $161.35 (market cap $30.10B). The key difference: Reddit Inc is the larger of the two by market cap, and Incyte Corporation is trading nearer its 52-week high, Reddit Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Incyte Corporation for 33 Days and Reddit Inc for 26 Days on average.
| INCY | RDDT | |
|---|---|---|
Market Cap | $22.85B | $30.10B |
Volume | 1,927,029 | 4,560,440 |
Sector | Health | Media |
52-Week High | $129.93 | $258.93 |
52-Week Low | $83.80 | $121.84 |
Typical Hold Time | 33 Days | 26 Days |
Enterprise Value | $18.35B | $27.34B |
Signals from Pluang's Aura AI — not financial advice
Incyte (INCY) trades at $113.61, up 0.15% on the day, with a mixed technical signal leaning bearish. The company reported strong 2025 results with revenue of $5.14B and net income of $1.29B, and recent earnings beats in Q1 and Q2 2026. Key developments include FDA approval for Atebrioz and a strategic focus on post-JAKAFI growth targeting $4B in non-JAKAFI sales by 2029.
The outlook is cautiously optimistic, supported by robust profitability and pipeline progress, but tempered by near-term earnings pressure and technical weakness. Risks include JAKAFI's patent expiration after 2029 and competitive threats. Analysts maintain a Buy consensus with a $132.43 price target, implying significant upside from current levels.
Reddit (RDDT) trades at $161.53, up 5.73% with strong earnings momentum after beating Q2 2026 EPS estimates. The stock shows bullish technical signals with support at $154 and resistance at $163. Fundamentally, the company maintains exceptional 91.44% gross margins and 31.35% net income margin, with revenue projected to grow from $2.2B to $2.8B in 2026. Recent news highlights international expansion and AI partnerships while facing competitive pressures.
Outlook remains positive with 65.52% analyst buy ratings and $202.52 consensus target, though risks include CEO stock sales and competitive threats. The valuation appears elevated at 36.39 P/E, but strong profitability and growth trajectory support the bullish case for investors seeking social media exposure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →